Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Renal Insufficiency Market?
The market size for renal insufficiency has been rapidly expanding of late. The market, valued at $10.87 billion in 2024, is expected to rise up to $12.14 billion in 2025, projecting a compound annual growth rate (CAGR) of 11.7%. This surge can be attributed to the growing incidences of hypertension and diabetes, an increased number of chronic kidney disease (CKD) cases, an uptick in urinary tract obstructions, an aging demographic, and heightened awareness and education concerning kidney health.
What Growth Rate Is Forecasted for the Renal Insufficiency Market by 2029?
In the coming years, the renal insufficiency market is anticipated to witness swift expansion, reaching a valuation of $18.68 billion in 2029, with a compound annual growth rate (CAGR) of 11.4%. Several factors contribute to this projected growth during the forecast period: the rising incidence of acute kidney injuries (AKI), the growing acceptance of home-based treatment options, increased healthcare spending, and investment in research and development. Expected trends for this period include breakthroughs in medical and treatment technologies, incorporation of personalized medicine, progress in dialysis technology, and the introduction of innovative drugs.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp
Which Key Companies Are Shaping the Future of the Renal Insufficiency Market?
Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation, Sorin Group.
Which Factors Are Driving Demand in the Renal Insufficiency Industry?
The growth of the renal insufficiency market is anticipated to be driven by the escalating number of diabetes and high blood pressure cases. These health issues stem from factors such as improper diet, insufficient physical exercise, obesity, hereditary predisposition, and an aging populace. High blood pressure leads to scarring and decreased filtration in kidney blood vessels, while high blood sugar in diabetes thickens and overworks the kidney vessels, hastening kidney damage and consequentially triggering renal insufficiency. For instance, the National Health Service, a UK-based government agency, reported in May 2024, that the number of patients diagnosed with high blood pressure in the South East increased by 71,120 or 5.4% in December 2023 compared to the same month in 2022. Additionally, as per the British Diabetic Association, a UK-based charity organization data from April 2023, 4.3 million individuals in the UK live with a diabetes diagnosis. As a result, the surge in high blood pressure and diabetes cases is fueling the progression of the renal insufficiency market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21271&type=smp
How Is the Renal Insufficiency Market Segmented by Several Divisions?
The renal insufficiency market covered in this report is segmented –
1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types
2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes
Subsegments:
1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate
2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)
3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy
4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy
What are the Emerging Market Trends Driving the Growth of the Renal Insufficiency Industry?
Key players in the renal insufficiency market are focusing on developing glucagon-like peptide-1 receptor agonists (GLP-1 RAs). This is aimed at managing both renal and cardiovascular complications in patients suffering from diabetes and chronic kidney disease (CKD). GLP-1 RAs work by improving glucose control, mitigating inflammation, and reducing oxidative stress on the kidneys, which slows the development of renal insufficiency. A prime example came in January 2025, when Danish pharmaceutical firm Novo Nordisk received approval from the Food and Drug Administration (FDA) for Ozempic (semaglutide), a drug aimed at diminishing the risk of kidney disease progression, kidney failure, and cardiovascular death in adults with CKD and type 2 diabetes. This approval underscores the increasing focus on GLP-1 RAs as a dual solution for managing diabetes and renal insufficiency, catering to significant unmet needs in patients with advancing CKD.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report
Which Regions Are Driving Growth in the Renal Insufficiency Market?
North America was the largest region in the renal insufficiency market in 2024. The regions covered in the renal insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21271
This Report Delivers Insight On:
1. How big is the renal insufficiency market, and how is it changing globally?
2. Who are the major companies in the renal insufficiency market, and how are they performing?
3. What are the key opportunities and risks in the renal insufficiency market right now?
4. Which products or customer segments are growing the most in the renal insufficiency market?
5. What factors are helping or slowing down the growth of the renal insufficiency market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model